Active Funding Opportunity Announcements (FOAs) for All NICHD | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number	Submissions Date(s)	Expiration Date	Activity Code(s)	Title
RFA-NS-19-022	April 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	April 11, 2019	U54	Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)
RFA-OD-19-018	March 14, 2019. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	March 15, 2019	R61/R33	Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required)
RFA-OD-19-015	March 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.	March 15, 2019	R21	INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
RFA-OD-19-016	March 14 2019 , by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	March 15, 2019	R01	Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
RFA-MH-20-210	June 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement	June 25, 2019	R24	Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)
RFA-AI-19-006	Only accepting applications for the AIDS Application Due Date listed below.	August 2, 2019	UM1	HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-002	Only accepting applications for the AIDS application Due Date listed below.	August 2, 2019	UM1	HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)
RFA-AI-19-004	Only accepting applications for the AIDS Application Due Date listed below.	August 2, 2019	UM1	HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-005	Only accepting applications for the AIDS Application Due Date listed below.	August 2, 2019	UM1	HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-001	Only accepting applications for the AIDS application Due Date listed below.	August 2, 2019	UM1	HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)
PA-19-165	February 20, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	February 21, 2019	333	Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
RFA-HD-19-024	April 4, 2019, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Only accepting applications for the AIDS Application Due Date(s) listed below.	May 15, 2019	R01	Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
PAR-19-163	Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.	September 8, 2021	R21	Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
PAR-19-135	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 25, 2019 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	January 8, 2022	R15	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
PAR-19-134	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 25, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	January 8, 2022	R15	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
PAR-19-133	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 25, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	January 8, 2021	R15	Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
RFA-DA-19-029	March 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	March 26, 2019	R34	HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed)
RFA-DA-19-036	March 25, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	March 26, 2019	R34	HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed)
PA-19-129	Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	January 8, 2022	K99/R00	NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)
PA-19-117	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	January 8, 2022	K08	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)